Yakup Ergün: The policy of some journals to collect accepted letters under a single heading is quite unfair
Yakup Ergün, Medical Oncologist at Ankara Numune Training and Research Hospital, shared on X:
“The policy of some journals (especially those in the LANCET group) to collect accepted letters under a single heading is quite unfair. Clinical trial articles are usually written by writing teams supported by industry sponsors and often bring together many researchers. In contrast, letters are usually the effort of one or a few independent researchers trying to make their voices heard on their own. At the very least, they should respect this effort and publish the letters under the titles chosen by the authors. I believe this would be fairer. This way, the intended message does not get lost under a general heading. Letters are not worthless. They strengthen articles by providing different perspectives.”
Source: Yakup Ergün/X
.
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023